Medicine for reducing blood sugar and preparation method thereof

The invention relates to a medicine for reducing blood sugar and a preparation method thereof. The pharmaceutical compound provided by the invention has very excellent GPR119 agonist activity, and can be used as a potential drug for treating diabetes, especially type II diabetes. The preparation method disclosed by the invention is simple, and the compound is high in yield, few in impurities, good in quality, outstanding in drug effect and suitable for industrial application..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 29. Aug. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

PARK SEONG-AE [VerfasserIn]
MENG TUO [VerfasserIn]
YUN JINGTING [VerfasserIn]
QIN PEIYAO [VerfasserIn]
LI BOJIA [VerfasserIn]
FU QIANG [VerfasserIn]
FU YIN [VerfasserIn]
HU XIAOYANG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-08-29, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08

Patentnummer:

CN116655598

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018561942